This recombinant monoclonal antibody is a research-grade biosimilar to BITR-2101, designed to specifically recognize TNFRSF1B (Tumor Necrosis Factor Receptor Superfamily Member 1B), also known as TNFR2 or CD120b. TNFRSF1B is a cell surface receptor that binds tumor necrosis factor-alpha (TNF-α) and plays a crucial role in regulating immune responses, cell survival, and inflammation. Unlike TNFRSF1A, which primarily mediates pro-inflammatory and apoptotic signaling, TNFRSF1B predominantly activates pro-survival pathways and modulates T regulatory cell function. This receptor is implicated in various pathological conditions including autoimmune diseases, chronic inflammatory disorders, cancer progression, and neurodegenerative diseases.
BITR-2101 has been utilized in research to investigate TNFRSF1B-mediated signaling pathways and its role in immune regulation. This biosimilar antibody provides researchers with a reliable tool for studying TNF-α receptor biology, exploring therapeutic targets in inflammatory and malignant diseases, and investigating the differential functions of TNF receptor subtypes in various cellular contexts.
Email: support@cusabio.com
Distributors Worldwide